BMD should be measured in women with chemotherapy-induced ovarian failure and particularly in patients taking aromatase inhibitors (eg, anastrozole, letrozole) (Table 3).

• 在治疗导致卵巢功能衰竭的妇女和使用芳香酶抑制剂（如阿纳托唑、来曲唑）的患者，骨矿物质密度需要测量。